"Dr Lucio Gordan earned his medical degree from the State University of Londrina College of Medicine in Londrina, Brazil, and later completed his internship and residen..."

During the past decade, Lucio Gordan, MD conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Lucio Gordan, MD" are "Carcinoma, Non-Small Cell Lung" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Lung Cancer" (1 trials), "Neoplasms, Lung" (1 trials) and "Neoplasms, Pulmonary" (1 trials). Many other conditions were trialed in "Lucio Gordan, MD" in a lesser frequency.

Most popular intervention types in "Lucio Gordan, MD" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "docetaxel" (1 trials), "pemetrexed" (1 trials), "talabostat" (1 trials) and "talabostat mesylate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lucio Gordan, MD" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Lucio Gordan, MD". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Lucio Gordan, MD, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Lucio Gordan, MD, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".